OC459

DRUG2 trials

Sponsors

Oxagen Ltd., Imperial College London

Conditions

AsthmaCommon ColdMild to moderate persistent asthma MedDRA version: 9.1 Level: LLT Classification code 10003553 Term: AsthmaPicornaviridae InfectionsRhinovirus

Phase 2

Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

CompletedNCT02660489

Imperial College LondonAsthma, Common Cold, Picornaviridae Infections +1

Start: 2015-01-31End: 2018-02-28Updated: 2021-02-26

Unknown Phase

Dose Finding Study in Patients with Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral OC000459 Dosed at Three Dose Schedules for Twelve Weeks

Active, not recruitingEUCTR2008-006013-24-HU

Oxagen Ltd.Mild to moderate persistent asthma MedDRA version: 9.1 Level: LLT Classification code 10003553 Term: Asthma

Start: 2009-03-25Target: 900Updated: 2012-03-19